<DOC>
	<DOCNO>NCT02972658</DOCNO>
	<brief_summary>This study extension study I8D-MC-AZES ( NCT02245737 ) , AMARANTH study . The purpose study evaluate effectiveness study drug LY3314814 participant early Alzheimer 's disease dementia time entry study I8D-MC-AZES .</brief_summary>
	<brief_title>A Study LY3314814 Early Alzheimer 's Disease Dementia</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<criteria>Participants previously enrol AMARANTH ( NCT02245737 ) meet eligibility criterion delay start I8DMCAZFD . Participants participate AMARANTH ( NCT02245737 ) develop new condition preclude enrol I8DMCAZFD .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Alzheimer 's Disease</keyword>
	<keyword>Dementia</keyword>
	<keyword>Brain Diseases</keyword>
	<keyword>Neurodegenerative Diseases</keyword>
	<keyword>Central Nervous System Diseases</keyword>
	<keyword>Nervous System Diseases</keyword>
	<keyword>Mental Disorders</keyword>
	<keyword>Delirium , Dementia , Amnestic , Cognitive Disorders</keyword>
	<keyword>Tauopathies</keyword>
	<keyword>Memory</keyword>
	<keyword>Amyloid</keyword>
</DOC>